Concepedia

David Floyd

DF

Statistics

Publications

56

Citations

4.9K

H-Index

34

Active since

1964

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Sweden)

Institute for Medical Research

Bristol-Myers Squibb (Germany)

University of Washington

David Floyd is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

1964–2023

56

Publications

56

Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents

Karnail S. Atwal, Brian N. Swanson, Steven E. Unger et al. · Journal of Medicinal Chemistry · 1991 · 784 citations

, , +12

Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines

Karnail S. Atwal, George C. Rovnyak, S. David Kimball et al. · Journal of Medicinal Chemistry · 1990 · 378 citations

, , +8

Monocyclic β-lactam antibiotics produced by bacteria

R. B. Sykes, C. M. CIMARUSTI, D P Bonner et al. · Nature · 1981 · 300 citations

, , +11

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

José M. Coterón, María Marco, Jorge Esquivias et al. · Journal of Medicinal Chemistry · 2011 · 284 citations · Full text

, , +17

Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines

Karnail S. Atwal, George C. Rovnyak, Joseph E. Schwartz et al. · Journal of Medicinal Chemistry · 1990 · 284 citations · Full text

, , +13

1–5 of 56